Omnicell Com Financials
Omnicell Com (OMCL) reported $1.2B in revenue for fiscal year 2025, up 6.5% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Cash conversion is stronger than profits imply, but persistent margin compression keeps Omnicell operating close to break-even.
Across FY2023-FY2025, free cash flow stayed positive after capital spending even as net income stayed near break-even or below it. With annual depreciation and amortization still around$80M and capex well below operating cash flow, reported earnings look materially harsher than the cash economics of the installed base.
The post-FY2021 issue is margin structure, not demand alone: latest revenue is back above the earlier peak, but gross margin remains several points lower at
The balance sheet is being simplified: total liabilities fell to
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Omnicell Com's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Omnicell Com has an operating margin of 0.4%, meaning the company retains less than $1 of operating profit per $100 of revenue. This results in a moderate score of 30/100, indicating healthy but not exceptional operating efficiency. This is up from 0.0% the prior year.
Omnicell Com's revenue grew 6.5% year-over-year to $1.2B, a solid pace of expansion. This earns a growth score of 37/100.
Omnicell Com has a moderate D/E ratio of 0.60. This balance of debt and equity financing earns a leverage score of 56/100.
Omnicell Com's current ratio of 1.43 indicates adequate short-term liquidity, earning a score of 38/100. The company can meet its near-term obligations, though with limited headroom.
Omnicell Com converts 7.3% of revenue into free cash flow ($86.9M). This strong cash generation earns a score of 68/100.
Omnicell Com generates a 0.2% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 29/100. This is down from 1.0% the prior year.
Omnicell Com scores 2.33, placing it in the grey zone between 1.81 and 2.99. The score is driven primarily by a large market capitalization ($1.6B) relative to total liabilities ($742.9M). This signals moderate financial risk that warrants monitoring.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Omnicell Com passes 7 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, both operating efficiency signals pass.
Omnicell Com reported $2.1M of net income while generating $127.3M in operating cash flow. The ratio between the two is outside the range this page publishes as a per-dollar figure, so both figures are given instead.
Key Financial Metrics
Earnings & Revenue
Omnicell Com generated $1.2B in revenue in fiscal year 2025. This represents an increase of 6.5% from the prior year.
Omnicell Com's EBITDA was $84.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 1.7% from the prior year.
Omnicell Com reported $2.1M in net income in fiscal year 2025. This represents a decrease of 83.6% from the prior year.
Omnicell Com earned $0.04 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 85.2% from the prior year.
Cash & Balance Sheet
Omnicell Com generated $86.9M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 42.6% from the prior year.
Omnicell Com held $196.5M in cash as of fiscal year 2025; long-term debt is not reported for that period.
Not reported for fiscal year 2025.
Margins & Returns
Omnicell Com's gross margin was 42.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.1 percentage points from the prior year.
Omnicell Com's operating margin was 0.4% in fiscal year 2025, reflecting core business profitability. This is up 0.4 percentage points from the prior year.
Omnicell Com's net profit margin was 0.2% in fiscal year 2025, showing the share of revenue converted to profit. This is down 1.0 percentage points from the prior year.
Omnicell Com's ROE was 0.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 0.8 percentage points from the prior year.
Capital Allocation
Omnicell Com invested $88.7M in research and development in fiscal year 2025. This represents a decrease of 1.9% from the prior year.
Omnicell Com spent $77.6M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.
Omnicell Com invested $40.4M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 10.8% from the prior year.
OMCL Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.2B | $1.2B+6.5% | $1.1B-3.0% | $1.1B-11.5% | $1.3B+14.5% | $1.1B+26.9% | $892.2M-0.5% | $897.0M+13.9% | $787.3M+10.5% | $712.7M+2.4% | $695.9M+43.6% | $484.6M+9.9% | $440.9M+15.8% | $380.6M+21.2% | $314.0M+27.9% | $245.5M |
| Cost of Revenue | $688.6M | $681.4M+6.3% | $641.2M-1.4% | $650.3M-8.0% | $707.0M+22.4% | $577.4M+20.6% | $478.9M+4.1% | $460.1M+10.9% | $415.0M+5.3% | $394.1M+4.0% | $378.8M+60.1% | $236.6M+14.3% | $207.0M+16.8% | $177.2M+23.5% | $143.4M+30.7% | $109.8M |
| Gross Profit | $558.1M | $503.4M+6.9% | $471.0M-5.2% | $496.8M-15.6% | $589.0M+6.2% | $554.7M+34.2% | $413.3M-5.4% | $436.9M+17.3% | $372.3M+16.9% | $318.6M+0.5% | $317.1M+27.9% | $247.9M+6.0% | $233.9M+15.0% | $203.4M+19.2% | $170.6M+25.6% | $135.8M |
| R&D Expenses | $88.4M | $88.7M-1.9% | $90.4M-6.9% | $97.1M-7.5% | $105.0M+38.6% | $75.7M+7.9% | $70.2M+2.2% | $68.6M+5.9% | $64.8M-1.8% | $66.0M+14.2% | $57.8M+64.4% | $35.2M+26.5% | $27.8M-4.5% | $29.1M+22.7% | $23.7M+7.6% | $22.0M |
| SG&A Expenses | $411.8M | $409.6M+7.7% | $380.3M-12.5% | $434.6M-10.6% | $486.3M+24.9% | $389.4M+26.6% | $307.6M+6.1% | $289.9M+10.2% | $263.1M+9.0% | $241.5M+1.5% | $237.9M+41.9% | $167.6M+7.1% | $156.5M+12.6% | $139.0M+16.1% | $119.7M+22.8% | $97.5M |
| Operating Income | $58.0M | $5.2M+1431.2% | $337K+101.0% | -$34.9M-1401.0% | -$2.3M-102.6% | $89.5M+151.9% | $35.5M-54.7% | $78.4M+76.5% | $44.4M+298.3% | $11.1M-47.9% | $21.4M-56.0% | $48.6M-1.9% | $49.6M+40.5% | $35.3M+30.1% | $27.1M+67.2% | $16.2M |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $3.6M-52.0% | $7.5M+19.0% | $6.3M+18.9% | $5.3M | $0 | N/A | N/A | N/A | $62K |
| Income Tax | $22.1M | $9.3M-29.0% | $13.1M+4866.5% | $263K+103.2% | -$8.1M+31.6% | -$11.8M-316.2% | -$2.8M-122.6% | $12.6M+696.1% | -$2.1M+91.9% | -$26.0M-907.6% | $3.2M-79.2% | $15.5M-13.9% | $18.0M+62.8% | $11.1M+1.4% | $10.9M+91.2% | $5.7M |
| Net Income | $39.1M | $2.1M-83.6% | $12.5M+161.5% | -$20.4M-460.7% | $5.6M-92.7% | $77.8M+141.8% | $32.2M-47.5% | $61.3M+62.6% | $37.7M+23.6% | $30.5M+212.8% | $9.8M-68.3% | $30.8M+0.8% | $30.5M+27.3% | $24.0M+48.2% | $16.2M+55.7% | $10.4M |
| EPS (Diluted) | — | $0.04-85.2% | $0.27+160.0% | -$0.45-475.0% | $0.12-92.6% | $1.62+118.9% | $0.74-48.3% | $1.43+53.8% | $0.93+17.7% | $0.79+203.8% | $0.26-69.0% | $0.84+1.2% | $0.83+23.9% | $0.67+42.6% | $0.47+56.7% | $0.30 |
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
OMCL Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.0B-6.9% | $2.1B-4.8% | $2.2B+0.7% | $2.2B+3.2% | $2.1B+17.4% | $1.8B+47.0% | $1.2B+14.8% | $1.1B+6.4% | $1.0B+8.7% | $935.1M+61.6% | $578.7M+3.3% | $560.2M+13.7% | $492.5M+11.5% | $441.8M+21.4% | $363.8M |
| Current Assets | $680.1M-16.6% | $815.5M-12.1% | $927.6M+5.2% | $881.8M+13.0% | $780.7M-5.9% | $829.4M+71.6% | $483.2M+21.7% | $397.1M+12.7% | $352.3M+11.7% | $315.4M+19.4% | $264.1M-6.8% | $283.4M+21.2% | $233.8M+29.3% | $180.8M-36.3% | $283.6M |
| Cash & Equivalents | $196.5M-46.8% | $369.2M-21.1% | $468.0M+41.7% | $330.4M-5.4% | $349.1M-28.2% | $485.9M+282.0% | $127.2M+89.3% | $67.2M+107.2% | $32.4M-40.5% | $54.5M-33.7% | $82.2M-34.7% | $125.9M+20.4% | $104.5M+67.8% | $62.3M-67.5% | $191.8M |
| Inventory | $100.9M+13.8% | $88.7M-19.5% | $110.1M-25.4% | $147.5M+23.0% | $119.9M+24.5% | $96.3M-10.8% | $108.0M+7.1% | $100.9M+4.9% | $96.1M+38.7% | $69.3M+48.7% | $46.6M+47.7% | $31.6M+0.3% | $31.5M+16.9% | $26.9M+48.6% | $18.1M |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | $196.2M+3.3% | $190.0M+26.4% | $150.3M+39.2% | $108.0M+30.4% | $82.8M+41.2% | $58.6M+6.3% | $55.1M+42.6% | $38.7M |
| Goodwill | $737.9M+0.4% | $734.7M-0.1% | $735.8M+0.2% | $734.3M-0.6% | $738.9M+48.0% | $499.3M+48.4% | $336.5M+0.2% | $335.9M-0.6% | $337.8M+3.1% | $327.7M+121.6% | $147.9M+20.5% | $122.7M+10.2% | $111.3M-0.1% | $111.4M+290.3% | $28.5M |
| Total Liabilities | $742.9M-15.4% | $877.6M-15.4% | $1.0B-4.0% | $1.1B+8.5% | $995.8M+16.2% | $857.0M+116.7% | $395.6M-1.5% | $401.6M-13.1% | $462.0M-8.2% | $503.5M+185.5% | $176.4M+3.7% | $170.1M+18.5% | $143.5M+6.9% | $134.3M+65.9% | $80.9M |
| Current Liabilities | $476.6M-20.0% | $595.7M+62.0% | $367.8M-14.2% | $428.4M-51.1% | $876.2M+217.0% | $276.4M+16.6% | $237.0M+15.8% | $204.6M-0.3% | $205.2M+13.4% | $180.9M+45.2% | $124.6M+10.9% | $112.3M+21.6% | $92.4M+11.2% | $83.1M+37.0% | $60.6M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | $50.0M-63.1% | $135.4M-30.5% | $194.9M-20.7% | $245.7M | $0 | N/A | N/A | N/A | N/A |
| Total Equity | $1.2B-0.9% | $1.2B+4.6% | $1.2B+5.2% | $1.1B-1.4% | $1.1B+18.5% | $967.5M+14.5% | $845.3M+24.4% | $679.6M+22.6% | $554.3M+20.8% | $458.8M+9.1% | $420.5M+7.8% | $390.1M+11.8% | $349.0M+13.5% | $307.6M+8.7% | $282.9M |
| Retained Earnings | $384.9M+0.5% | $382.9M+3.4% | $370.4M-5.2% | $390.7M+6.0% | $368.6M+26.8% | $290.7M+12.3% | $258.8M+31.1% | $197.5M+23.6% | $159.7M+59.1% | $100.4M+0.6% | $99.8M+44.6% | $69.0M+79.2% | $38.5M+165.0% | $14.5M+985.3% | -$1.6M |
OMCL Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $181.4M | $127.3M-32.2% | $187.7M+3.7% | $181.1M+132.8% | $77.8M-66.4% | $231.8M+24.7% | $185.9M+28.2% | $145.0M+39.5% | $104.0M+318.6% | $24.8M-50.2% | $49.9M+29.7% | $38.5M-40.9% | $65.2M+17.9% | $55.3M+40.0% | $39.5M+26.4% | $31.2M |
| Capital Expenditures | $38.8M | $40.4M+10.8% | $36.5M-12.1% | $41.5M-12.8% | $47.5M+64.1% | $29.0M+26.8% | $22.8M+43.7% | $15.9M-32.9% | $23.7M+54.5% | $15.3M+14.1% | $13.4M+78.3% | $7.5M-36.7% | $11.9M-3.3% | $12.3M-18.4% | $15.1M+74.1% | $8.7M |
| Free Cash Flow | $142.6M | $86.9M-42.6% | $151.3M+8.3% | $139.6M+361.6% | $30.2M-85.1% | $202.8M+24.4% | $163.0M+26.3% | $129.1M+60.9% | $80.3M+745.6% | $9.5M-74.0% | $36.5M+17.8% | $30.9M-41.9% | $53.2M+24.0% | $42.9M+76.2% | $24.4M+8.0% | $22.6M |
| Investing Cash Flow | -$57.1M | -$60.4M-14.3% | -$52.8M+4.0% | -$55.0M+6.2% | -$58.7M+85.8% | -$412.5M-47.4% | -$279.9M-353.9% | -$61.7M-13.4% | -$54.4M-55.4% | -$35.0M+89.7% | -$341.3M-648.6% | -$45.6M-5.2% | -$43.3M-111.8% | -$20.5M+87.9% | -$168.7M | N/A |
| Financing Cash Flow | -$231.9M | -$218.3M+7.3% | -$235.6M-1105.9% | $23.4M+211.8% | -$21.0M-144.2% | $47.4M-89.6% | $456.3M+2043.3% | -$23.5M-72.7% | -$13.6M-37.7% | -$9.9M-103.7% | $263.8M+821.5% | -$36.6M-17646.1% | -$206K-102.8% | $7.4M+3278.4% | -$232K | N/A |
| Share Buybacks | N/A | $77.6M | $0 | $0-100.0% | $52.2M | $0-100.0% | $53.0M | $0 | $0 | $0 | $0-100.0% | $50.0M+107.6% | $24.1M+14.9% | $21.0M+69.6% | $12.4M-1.7% | $12.6M |
Not reported in any period shown, so not listed: Dividends Paid.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
OMCL Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 42.5%+0.1pp | 42.4%-1.0pp | 43.3%-2.1pp | 45.5%-3.5pp | 49.0%+2.7pp | 46.3%-2.4pp | 48.7%+1.4pp | 47.3%+2.6pp | 44.7%-0.9pp | 45.6%-5.6pp | 51.2%-1.9pp | 53.0%-0.4pp | 53.4%-0.9pp | 54.3%-1.0pp | 55.3% |
| Operating Margin | 0.4%+0.4pp | 0.0%+3.1pp | -3.0%-2.9pp | -0.2%-8.1pp | 7.9%+3.9pp | 4.0%-4.8pp | 8.7%+3.1pp | 5.6%+4.1pp | 1.6%-1.5pp | 3.1%-7.0pp | 10.0%-1.2pp | 11.3%+2.0pp | 9.3%+0.6pp | 8.6%+2.0pp | 6.6% |
| Net Margin | 0.2%-1.0pp | 1.1%+2.9pp | -1.8%-2.2pp | 0.4%-6.4pp | 6.9%+3.3pp | 3.6%-3.2pp | 6.8%+2.1pp | 4.8%+0.5pp | 4.3%+2.9pp | 1.4%-5.0pp | 6.3%-0.6pp | 6.9%+0.6pp | 6.3%+1.2pp | 5.1%+0.9pp | 4.2% |
| Return on Equity | 0.2%-0.8pp | 1.0%+2.7pp | -1.7%-2.2pp | 0.5%-6.3pp | 6.8%+3.5pp | 3.3%-3.9pp | 7.3%+1.7pp | 5.5%0.0pp | 5.5%+3.4pp | 2.1%-5.2pp | 7.3%-0.5pp | 7.8%+1.0pp | 6.9%+1.6pp | 5.3%+1.6pp | 3.7% |
| Return on Assets | 0.1%-0.5pp | 0.6%+1.5pp | -0.9%-1.2pp | 0.3%-3.4pp | 3.6%+1.9pp | 1.8%-3.2pp | 4.9%+1.4pp | 3.5%+0.5pp | 3.0%+2.0pp | 1.0%-4.3pp | 5.3%-0.1pp | 5.5%+0.6pp | 4.9%+1.2pp | 3.7%+0.8pp | 2.9% |
| Current Ratio | 1.43+0.1x | 1.37-1.2x | 2.52+0.5x | 2.06+1.2x | 0.89-2.1x | 3.00+1.0x | 2.04+0.1x | 1.94+0.2x | 1.720.0x | 1.74-0.4x | 2.12-0.4x | 2.520.0x | 2.53+0.4x | 2.18-2.5x | 4.68 |
| Debt-to-Equity | 0.60-0.1x | 0.71-0.2x | 0.87-0.1x | 0.96+0.1x | 0.870.0x | 0.89+0.8x | 0.06-0.1x | 0.20-0.2x | 0.35-0.2x | 0.54+0.5x | 0.00-0.4x | 0.440.0x | 0.410.0x | 0.44+0.2x | 0.29 |
| FCF Margin | 7.3%-6.3pp | 13.6%+1.4pp | 12.2%+9.8pp | 2.3%-15.6pp | 17.9%-0.4pp | 18.3%+3.9pp | 14.4%+4.2pp | 10.2%+8.9pp | 1.3%-3.9pp | 5.2%-1.1pp | 6.4%-5.7pp | 12.1%+0.8pp | 11.3%+3.5pp | 7.8%-1.4pp | 9.2% |
Similar Companies
Where Omnicell Com Ranks
Frequently Asked Questions
What is Omnicell Com's annual revenue?
Omnicell Com (OMCL) reported $1.2B in total revenue for fiscal year 2025. This represents a 6.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Omnicell Com's revenue growing?
Omnicell Com (OMCL) revenue grew by 6.5% year-over-year, from $1.1B to $1.2B in fiscal year 2025.
Is Omnicell Com profitable?
Yes, Omnicell Com (OMCL) reported a net income of $2.1M in fiscal year 2025, with a net profit margin of 0.2%.
What is Omnicell Com's EBITDA?
Omnicell Com (OMCL) had EBITDA of $84.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Omnicell Com's gross margin?
Omnicell Com (OMCL) had a gross margin of 42.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Omnicell Com's operating margin?
Omnicell Com (OMCL) had an operating margin of 0.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Omnicell Com's net profit margin?
Omnicell Com (OMCL) had a net profit margin of 0.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Omnicell Com's return on equity (ROE)?
Omnicell Com (OMCL) has a return on equity of 0.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Omnicell Com's free cash flow?
Omnicell Com (OMCL) generated $86.9M in free cash flow during fiscal year 2025. This represents a -42.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Omnicell Com's operating cash flow?
Omnicell Com (OMCL) generated $127.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Omnicell Com's total assets?
Omnicell Com (OMCL) had $2.0B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Omnicell Com's capital expenditures?
Omnicell Com (OMCL) invested $40.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Omnicell Com spend on research and development?
Omnicell Com (OMCL) invested $88.7M in research and development during fiscal year 2025.
What is Omnicell Com's current ratio?
Omnicell Com (OMCL) had a current ratio of 1.43 as of fiscal year 2025, which is considered adequate.
What is Omnicell Com's debt-to-equity ratio?
Omnicell Com (OMCL) had a debt-to-equity ratio of 0.60 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Omnicell Com's return on assets (ROA)?
Omnicell Com (OMCL) had a return on assets of 0.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Omnicell Com's Altman Z-Score?
Omnicell Com (OMCL) has an Altman Z-Score of 2.33, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Omnicell Com's Piotroski F-Score?
Omnicell Com (OMCL) has a Piotroski F-Score of 7 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Omnicell Com's earnings high quality?
Omnicell Com (OMCL) reported $2.1M of net income while generating $127.3M in operating cash flow. The ratio between the two is outside the range this page publishes as a per-dollar figure, so both figures are given instead. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Omnicell Com?
Omnicell Com (OMCL) scores 43 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.